NCT02998931View on ClinicalTrials.gov

Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

August 25, 2018

Study Completion Date

September 10, 2018

Conditions
Critical IllnessEnteral NutritionMultiple Organ FailureInfection ComplicationInflammation
Interventions
DRUG

Glutamin

Enteral Glutamine 0.3g/kg/day powdered glutamine to be mixed in with water and given via nasogastric tube q4 hrs

OTHER

Maltodextrin

Maltodextrin mixed with water given via NG tube Q 4 hours

Trial Locations (2)

Unknown

Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran

Shohada Tajrish Hospital, Tehran

All Listed Sponsors
lead

Shahid Beheshti University

OTHER

NCT02998931 - Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients | Biotech Hunter | Biotech Hunter